US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
NASDAQ
Skye Bioscience Inc (SKYE) 銘柄情報

Skye Bioscience Inc (SKYE)

0.69

-0.0109

(-1.56%)

終了 7月12日 5:00AM

0.7038

0.0138

(2.00%)

取引時間後: 7:14AM

Skye Bioscience Inc (SKYE) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.7038

( 0.41% )

買値

0.6703

売値

0.6898

出来高

184,958

平均取引量 (3 か月)

US$ 182,125

財務取引量

US$ 128,642

0.6721 日の範囲 0.71

0.5655 52 週間の範囲 4.9902

時価総額

企業価値

7.821M

前日終値

0.7009

始値

0.70

時刻

最終取引時間

VWAP

0.69552

歳入

-

純利益

-57.33M

発行済株式数

35,143,722

浮動株比率 (%)

65.36%

機関投資家保有比率 (%)

45.24%

配当利回り

PER

-0.48

株価売上高倍率 (PSR)

-

1 株当たり利益 (EPS)

-1.45

ベータ

2.94

Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating ant... Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California. 詳細を表示

セクター

Health Care

業界

-

ウェブサイト

skyebioscience.com

本社

San Diego, United States

設立

-

Skye Bioscience Inc is listed in the Health Care sector of the ナスダック市場 with ticker SKYE. The last closing price for Skye Bioscience was US$0.70. Over the last year, Skye Bioscience shares have traded in a share price range of US$ 0.5655 to US$ 4.9902.

Skye Bioscience currently has 35,143,722 shares in issue. The market capitalisation of Skye Bioscience is US$24.73 million. Skye Bioscience has a price to earnings ratio (PE ratio) of -0.48.

Form 8-K - Current report

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

Form PRE 14A - Other preliminary proxy statements

Form PREM14A - Preliminary proxy statements relating to merger or acquisition

Form 8-K/A - Current report: [Amend]

Form 8-K - Current report

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.0038	0.542857142857	0.7	0.7193	0.69	51532	0.70319881	CS
4	-0.1086	-13.3677991137	0.8124	0.8154	0.67	112422	0.70504196	CS
12	-0.0471	-6.27247303236	0.7509	1.12	0.67	173739	0.81180039	CS
26	-0.3062	-30.3168316832	1.01	1.12	0.5655	361286	0.79761986	CS
52	-3.4962	-83.2428571429	4.2	4.9902	0.5655	490097	1.66883318	CS
156	-12.7962	-94.7866666667	13.5	17.6473	0.5655	459211	2.65838651	CS
260	-12.7962	-94.7866666667	13.5	17.6473	0.5655	459211	2.65838651	CS

SKYE - Frequently Asked Questions (FAQ)

What is the current Skye Bioscience Inc share price?

The current share price of Skye Bioscience Inc is US$ 0.7038

How many Skye Bioscience Inc shares are in issue?

Skye Bioscience Inc has 35,143,722 shares in issue

What is the market cap of Skye Bioscience Inc?

The market capitalisation of Skye Bioscience Inc is USD 24.73M

What is the 1 year trading range for Skye Bioscience Inc share price?

Skye Bioscience Inc has traded in the range of US$ 0.5655 to US$ 4.9902 during the past year

What is the PE ratio of Skye Bioscience Inc?

The price to earnings ratio of Skye Bioscience Inc is -0.48

What is the registered address of Skye Bioscience Inc?

The registered address for Skye Bioscience Inc is 11250 El Camino Real, San Diego, California, 92130

What is the Skye Bioscience Inc website address?

The website address for Skye Bioscience Inc is skyebioscience.com

Doc logic

Doc logic 7分前

brazen22,

I am sure the company knows what they need too. Glad we can agree on that; ). Best wishes.

gdl

New Highs established. Resets any talk of CRASH for 2 plus months. News articles already discuss the roller coaster ride we should have this earnings season.
Once the TOP has need reestablished i count down from there 40 trading days. Getting close to the mid-terms is a hard task to (allow

jammy32

jammy32 10分前

What was her contribution to Elite -

Kristine Hakim owns 2,223,147 shares of Elite Pharmaceuticals (OTCPK: ELTP). Regardless , good for her. Glad the family gets to benefit from elite, the public traded company.

All my opinion

brazen22

brazen22 11分前

Doc, perhaps NWBO believes it is prepared and already earned its manufacturing merit badge. When it had the opportunity to address the scientific community at BNOS, it didn't present a manufacturing update, it presented a new survival-benefit analysis. Maybe the company knows which requirement still

gdl

New Highs resets any discussion of a CRASH. At a minimum it will be no earlier than September. Expect a roller coaster ride earing season as many articles have predicted. I suspect earnings will have dramatic shifts and disappointment. BUT we first have to establish when the top will be seen. I co

CryptoRain

CryptoRain 14分前

Nothing remotely like nsav and if you really believed that you wouldn’t have bought back in. Everything you throw out is derogatory and maybe, just maybe, you are incredibly wrong

Midwestrader

Midwestrader 15分前

DOWN 99% on Friday. Now a SIX DIGIT NO BID FRAUD.

From 41 CENTS in August 2024 after the MASSIVE 1 FOR 2500 RS to a pathetic 0.000001

https://investorshub.advfn.com/uimage/uploads/2026/7/6/ybtliINND_PERCENTAGE_DUMP_12_MONTH_.jpg

DUMP MATTY DU

jammy32

jammy32 16分前

Gosh all this good news is killing Elite. From 82 cents to 36 cents. Imagine what bad news would do. Hey , at least Nasrat is doing well and that’s all that we as investors can ask. Million per year, nice crib and Benz on the 5,000 per month and the five million bonus. Am I missing anyt

gdl

NEW HIGHS established. This can only result in at least 2 more months before any possible crash occurs. The financial articles that came out has warned that this earning season will be a roller coaster. they must see some dramatic changes in certain sectors to say that.

I frankly

theorysuit

theorysuit 18分前

Yet is the key word. The appeal process is why they chose the UK. This scamco would already be finished if they updated the status of their application which is why they remain silent. Csuite need to try and keep the gravy train alive as long as possible. They extended it out a few years

mascale

mascale 23分前

Qatar-land associates: Among world's top ten richest nations!

shajandr

shajandr 24分前

RYES = mining scam

Moe2001

Moe2001 26分前

Down on 10$ volume . if we could buy this wouldn’t be at these prices .

CanItBThisEZ2Make

CanItBThisEZ2Make 27分前

BEST SELLERS RANK (BSR) IS 746 6 Estimated Sold on Amazon Since JULY 1 - 3RD Quarter 2026
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Dec

theorysuit

theorysuit 29分前

Wow look how the cans keep getting kicked down the road....day after day, month after month, year after year, and before you know it decades after decades. Total and utter scam to enrich csuite ...already got their money invested many times over with cognate plus the decades of annual salaries and

Doc logic

Doc logic 32分前

brazen22,

You must never have been in scouting or raised by folks that went through the Great Depression. The motto and constant refrain is and was “be prepared”!; ). We are due right now for a manufacturing update because it’s been two years since the last failure to launch. Best

EZ2

11-12-23-24. 🙏

upper11

upper11 42分前

MusicExec

MusicExec 43分前

It’s not about winning
It’s about ensuring that unsophisticated retail investors such as yourself are aware of the risks and are able to make informed decisions of your own before you risk losing yet more of your money on this stock

garrox

garrox 46分前

Probably not, Anthropic will IPO a few weeks later.

ssc

Prevaricated naked short claims, preferred share dividend nonsense, illogical rights offering idea, and your latest direct registering - that's a big 0 for 4 continuing a perfect record of being wrong about dbmm and multiple other triple zero losers.

Implanting

Implanting 51分前

This week's insights from Chris Whalen. He sees a rate HIKE coming before the midterm elections. If he's right on that we should see lower PM prices to follow. He claims the White House has already given their blessing to do it. We'll see.

If inflation continues to move as high as he

Dennis14

Dennis14 52分前

https://www.reddit.com/answers/3b4ea622-26a1-4941-9634-d59dcb88e477/?q=MEHA+stock&source=SERP&upstreamCID=81ac40dc-46f4-4412-82a2-43664d3a926d&upstreamIID=1a5609c4-2627-4e9d-99d6-b1b6cc80b519&upstreamQ=MEHA+stock&upstreamQID=42b1640a-2845-4306-833d-d0c2fd72847a

Thomas@yahoo

Thomas@yahoo 52分前

💥🍿🤗 https://allegro.pl/listing?string=cultured%20foods

💥🍿🤗 https://www.instagram.com/p/DZu_k23E2FO/?igsh=MnJrdWs5eHlvZmc=

💥🍿🤗 https://ir.cvsciences.com/press-releases/detail/251/cv-sciences-expands-

Paullee

Paullee 57分前

Comment from SA article

Lewis Bosher
New: Yesterday,
247wallst.com/...

Another nice article came out today. Investors should remember Yves LeMaitre was CEO of Oclara and sold the company to Lumentum and then stayed on as Chief Strategy Officer for

Skye Bioscience

0.173% until 6july2027 0...

CTO Realty Growth

Riza Lecci Fundo De Inve...

Fundo De Investimento Im...

Arch Biopartners

Morgan Stanley Finance L...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。